ATE104551T1 - S-adenosylmethionin zur behandlung von pankreatitis und der immunabstossung des pankreastransplantates. - Google Patents

S-adenosylmethionin zur behandlung von pankreatitis und der immunabstossung des pankreastransplantates.

Info

Publication number
ATE104551T1
ATE104551T1 AT9090902247T AT90902247T ATE104551T1 AT E104551 T1 ATE104551 T1 AT E104551T1 AT 9090902247 T AT9090902247 T AT 9090902247T AT 90902247 T AT90902247 T AT 90902247T AT E104551 T1 ATE104551 T1 AT E104551T1
Authority
AT
Austria
Prior art keywords
pancreatitis
treatment
pct
adenosylmethionine
pancreas transplant
Prior art date
Application number
AT9090902247T
Other languages
English (en)
Inventor
Ian V Hutchinson
Joan M Braganza
Original Assignee
Bioresearch Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch Spa filed Critical Bioresearch Spa
Application granted granted Critical
Publication of ATE104551T1 publication Critical patent/ATE104551T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT9090902247T 1989-01-14 1990-01-10 S-adenosylmethionin zur behandlung von pankreatitis und der immunabstossung des pankreastransplantates. ATE104551T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898900812A GB8900812D0 (en) 1989-01-14 1989-01-14 Pharmaceutical method and compositions
PCT/EP1990/000048 WO1990007928A1 (en) 1989-01-14 1990-01-10 S-adenosyl-methionine in the treatment of pancreatitis and of the immuno rejection in the pancreas transplant

Publications (1)

Publication Number Publication Date
ATE104551T1 true ATE104551T1 (de) 1994-05-15

Family

ID=10650037

Family Applications (1)

Application Number Title Priority Date Filing Date
AT9090902247T ATE104551T1 (de) 1989-01-14 1990-01-10 S-adenosylmethionin zur behandlung von pankreatitis und der immunabstossung des pankreastransplantates.

Country Status (15)

Country Link
US (1) US5196402A (de)
EP (1) EP0408711B1 (de)
JP (1) JPH03503289A (de)
KR (1) KR910700055A (de)
AT (1) ATE104551T1 (de)
AU (1) AU630159B2 (de)
CA (1) CA2026580A1 (de)
DE (1) DE69008258T2 (de)
DK (1) DK0408711T3 (de)
ES (1) ES2055415T3 (de)
GB (1) GB8900812D0 (de)
HU (1) HU206626B (de)
RU (1) RU2014837C1 (de)
WO (1) WO1990007928A1 (de)
ZA (1) ZA90241B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243859B (it) * 1990-10-23 1994-06-28 Bioresearch Spa Composizioni farmaceutiche comprendenti associazioni fra sali di s-adenosil-l-metionina e acido 5-metil (o 5-formil)-tetraidrofolico per la terapia di complicanze neurologiche negli ammalati di aids.
US6492349B1 (en) 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
US5508262A (en) * 1993-12-15 1996-04-16 University Of South Florida Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
US5747461A (en) * 1994-07-26 1998-05-05 Markov; Angel K. Synergistic administration of cyclosporine and fructose diphosphate
US5723116A (en) * 1995-01-06 1998-03-03 University Of South Florida Decreased mortality of severe acute pancreatitis following proximal cytokine blockade
GB2312621B (en) * 1996-05-02 1998-03-11 Pharma Nord Uk Limited Anti-oxidant medicament
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
US6063600A (en) * 1997-05-23 2000-05-16 Uab Research Foundation DNA encoding canine interleukin-1 receptor antagonist
US6399093B1 (en) 1999-05-19 2002-06-04 Advanced Medical Instruments Method and composition to treat musculoskeletal disorders
US8168233B2 (en) * 2002-10-18 2012-05-01 Amylin Pharmaceuticals, Inc. Treatment of pancreatitis with amylin
US20050272687A1 (en) * 2004-06-08 2005-12-08 Hebert Rolland F Stable S-adenosyl-l-methionine
US20090012036A1 (en) * 2005-05-24 2009-01-08 Hebert Rolland F Stable S-adenosyl-L-methionine
US20100004191A1 (en) * 2008-07-01 2010-01-07 Rolland F Hebert Compositions of S-adenosyl-L-methionine.
CN102859023B (zh) 2010-03-30 2015-05-20 新日铁住金株式会社 高频淬火用钢、高频淬火用粗型材、其制造方法及高频淬火钢部件
WO2014059522A1 (en) * 2012-10-17 2014-04-24 Methylation Sciences International Srl Compositions comprising s-adenosylmethionine and a gallic acid ester

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1169772B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Composizioni terapeutiche per uso orale contenenti sali stabili della s-adenosil-l-metionina
IT1200589B (it) * 1985-02-14 1989-01-27 Gibipharma Spa Derivati naturali attivita farmagologica
DE3874352T2 (de) * 1987-10-09 1992-12-17 Vincenzo Zappia Lipophile salze von s-adenosyl-l-methionin (sam) mit acyltaurinderivaten.

Also Published As

Publication number Publication date
HU901516D0 (en) 1991-03-28
DE69008258D1 (de) 1994-05-26
JPH03503289A (ja) 1991-07-25
HUT54893A (en) 1991-04-29
DE69008258T2 (de) 1994-08-04
AU630159B2 (en) 1992-10-22
ES2055415T3 (es) 1994-08-16
KR910700055A (ko) 1991-03-13
EP0408711A1 (de) 1991-01-23
ZA90241B (en) 1991-03-27
DK0408711T3 (da) 1994-06-06
CA2026580A1 (en) 1990-07-15
HU206626B (en) 1992-12-28
AU5026090A (en) 1990-08-13
GB8900812D0 (en) 1989-03-08
RU2014837C1 (ru) 1994-06-30
EP0408711B1 (de) 1994-04-20
US5196402A (en) 1993-03-23
WO1990007928A1 (en) 1990-07-26

Similar Documents

Publication Publication Date Title
ATE104551T1 (de) S-adenosylmethionin zur behandlung von pankreatitis und der immunabstossung des pankreastransplantates.
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE59905954D1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
DE69309712T2 (de) Pharmazeutische und dermokosmetische mittel enthaltend pferdecolostrum
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
ATE240115T1 (de) Zusammensetzung zur vorbeugung und/oder behandlung der atherosklerose
PL321088A1 (en) Recombined antaginists of il-5 suitable in treating disorders associated with il-5
ATE152628T1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
DE69803773T2 (de) Yohimbine und arginin enthaltende zusammensetzung zur behandlung der erektilen fehlfunktion
ATE190843T1 (de) Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten
ATE179164T1 (de) Hiv-proteaseinhibitoren
ZA943171B (en) Thrombin-inhibitors.
ATE81467T1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
DE69526584T2 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
DE69023006D1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
DE69006360T2 (de) L-alpha-glycerophosphoryl-d-myoinositol zur behandlung peripherer neuropathien und cerebropathien.
ATE165509T1 (de) Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee